Over the last years, invasive infections caused by filamentous fungi have constituted a serious threat to public health worldwide. , , (the most common filamentous fungi), and (non-filamentous fungus) can cause infections in humans. They are able to cause critical life-threatening illnesses in immunosuppressed individuals, patients with HIV/AIDS, uncontrolled diabetes, hematological diseases, transplantation, and chemotherapy. In this review, we describe the available nanoformulations (both metallic and polymers-based nanoparticles) developed to increase efficacy and reduce the number of adverse effects after the administration of conventional antifungals. To treat aspergillosis and infections caused by , multiple strategies have been used to develop new therapeutic alternatives, such as incorporating coating materials, complexes synthesized by green chemistry, or coupled with polymers. However, the therapeutic options for coccidioidomycosis and mucormycosis are limited; most of them are in the early stages of development. Therefore, more research needs to be performed to develop new therapeutic alternatives that contribute to the progress of this field.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539376PMC
http://dx.doi.org/10.3390/pathogens10101303DOI Listing

Publication Analysis

Top Keywords

coccidioidomycosis mucormycosis
8
infections caused
8
filamentous fungi
8
develop therapeutic
8
therapeutic alternatives
8
nanomaterial-based antifungal
4
antifungal therapies
4
therapies combat
4
combat fungal
4
fungal diseases
4

Similar Publications

Fungal Musculoskeletal Infections: Comprehensive Approach to Proper Diagnosis.

Radiographics

July 2024

From the Department of Diagnostic Imaging, Escola Paulista de Medicina, Universidade Federal de São Paulo, Napoleão de Barros Street, 800 Vila Clementino, São Paulo, SP, Brazil 04024-002 (M.C.A., J.B.P., V.N.S., L.K.M., D.T.K., A.d.A.e.C., A.R.C.F., A.Y.A.); Department of Radiology, Hospital das Clínicas da Faculdade de Medicina de Marília, Marília, São Paulo, Brazil (M.C.A.); Department of Radiology, Montefiore Medical Center, The University Hospital for Albert Einstein College of Medicine, Bronx, NY (J.T.B.); Department of Diagnostic Imaging, Laboratório Delboni, DASA, São Paulo, Brazil (J.B.P., V.N.S., L.K.M., D.T.K., A.Y.A.); Department of Radiology, Hospital do Coração, HCor and Teleimagem, São Paulo, Brazil (V.N.S.); Department of Infectious Diseases, Universidade Federal de São Paulo, São Paulo, Brazil (A.M.D.); Hospital Israelita Albert Einstein, São Paulo, Brazil (A.d.A.e.C.); and Department of Radiology, Grupo de Radiologia e Diagnóstico por Imagem-Rede D'Or, São Paulo, Brazil (A.R.C.F.).

Article Synopsis
  • Fungal musculoskeletal infections can be challenging to identify due to their subtle symptoms and rarity, often overlapping with other diseases.
  • These infections spread through blood, direct contact, or nearby tissue extension, with risk factors including weakened immune systems and exposure at work, and can either be isolated or part of broader systemic issues.
  • Imaging plays a key role in diagnosis, revealing nonspecific signs like bone destruction and joint changes, but may also provide clues when combined with patient history and geographical context.
View Article and Find Full Text PDF

Invasive fungal infections and oomycoses in cats 2. Antifungal therapy.

J Feline Med Surg

January 2024

Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong, SAR China.

Article Synopsis
  • Invasive fungal infections (IFIs) and fungal-like infections (IFLIs) are challenging to treat due to long treatment times, the potential for relapse, and variable antifungal drug effectiveness.
  • The article aims to review the activity, mechanisms, and side effects of antifungal drugs, while discussing the treatment and prognosis for specific infections such as cryptococcosis and mucormycosis.
  • Information is primarily based on pharmacokinetic studies in cats, along with data from preclinical and human studies, combining insights from various veterinary specialties.
View Article and Find Full Text PDF

Innovative and potential treatments for fungal central nervous system infections.

Curr Opin Microbiol

December 2023

Department of Oral Biology, College of Dentistry, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA; Center for Immunology and Transplantation, Gainesville, FL, USA; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, USA. Electronic address:

Fungal infections of the central nervous system (FI-CNS) are a problematic and important medical challenge considering that those most affected are immunocompromised. Individuals with systemic cryptococcosis (67-84%), candidiasis (3-64%), blastomycosis (40%), coccidioidomycosis (25%), histoplasmosis (5-20%), mucormycosis (12%), and aspergillosis (4-6%) are highly susceptible to develop CNS involvement, which often results in high mortality (15-100%) depending on the mycosis and the affected immunosuppressed population. Current antifungal drugs are limited, prone to resistance, present host toxicity, and show reduced brain penetration, making FI-CNS very difficult to treat.

View Article and Find Full Text PDF

Hospitalizations involving fungal infections increased 8.5% each year in the United States during 2019-2021. During 2020-2021, patients hospitalized with COVID-19-associated fungal infections had higher (48.

View Article and Find Full Text PDF

The Impact of Corticosteroids on the Outcome of Fungal Disease: a Systematic Review and Meta-analysis.

Curr Fungal Infect Rep

February 2023

Manchester Fungal Infection Group, The University of Manchester, Manchester Academic Health Sciences Centre, Manchester, M23 9LT UK.

Purpose Of Review: Corticosteroids have a complex relationship with fungal disease - risk for many, benefit for others. This systematic review aims to address the effect of corticosteroids on mortality and visual outcome in different fungal diseases.

Recent Findings: Corticosteroids are a risk factor of aspergillosis for patients who have COVID-19, and they also led to a worse outcome.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!